November 9, 2016
Change to Astrazeneca board of directors
AstraZeneca has announced that Jean-Philippe Courtois, a Non-Executive Director, will step down from the Board of AstraZeneca…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
November 9, 2016
Viking Therapeutics' Chairman joins Dechra Pharmaceuticals' board
Dechra has appointed Lawson Macartney to the Board
November 9, 2016
Oxford Pharma's OXPzero Ibuprofen going back into the clinic
Oxford Pharma’s OXPzero Ibuprofen going back into the clinic
November 9, 2016
Valneva reports financial results for first nine months of 2016
Valneva has reported financial results for first nine months of 2016.
November 9, 2016
Nicox: update on Latanoprostene bunod and AC-170
Nicox S.A., the international ophthalmic R&D company, has provided an update on the regulatory status of its key projects, latanoprostene bunod and AC-170.
November 8, 2016
BD launches first syringe designed for use with Humulin R U-500 insulin
BD has announced the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin …
November 8, 2016
GENFIT's revenue halves in Q3 2016
GENFIT has today announced its cash and cash equivalents as at September 30, 2016
November 8, 2016
Esperite's revenue slightly lifted in Q3 compared to same period last year
The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased
November 8, 2016
After $195 million in talc verdicts, J&J strives to change court
After a $67.5 million jury verdict against Johnson & Johnson…
November 8, 2016
DBV Technologies closes down phase II study of Viaskin Milk
DBV Technologies has completed the enrollment for Part B, or Phase II, of the Phase I/II study of Viaskin Milk